Strides To Arm GLP-1 Generics Ahead Of LoEs, As Novo Spars Over Semaglutide Capacity

Primed To Tap $60bn Opportunity

 
• By Vibha Ravi
  
GLP-1Agonists - A representative image using Ozempic, Wegovy, Trulicity, Victoza, Mounjaro newspaper cuttings
Can CDMOs Help Address Shortage Of GLP-1 Agonists?

More from Strategy

More from Earnings